EGFR and lung carcinoma: Targeted molecular therapy has been successfully applied in several tumors, including ER(+) and HER2(+) breast cancer and epidermal growth factor receptor (EGFR)‐mutated lung cancer [8, 9, 10, 11], thus demonstrating great progress in precision medical treatment.